![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 46, 33155-33160, November 12, 1999
From the Department of Physiological Science, University of
California, Los Angeles, California 90095-1527
Mechanical stimuli can cause changes in muscle
mass and structure which indicate that mechanisms exist for transducing
mechanical stimuli into signals that influence gene expression.
Myotendinous junctions show adaptations to modified muscle loading
which suggest that these are transcriptionally distinct domains in
muscle fibers that may experience local regulation of expression of
structural proteins that are concentrated at these sites. Vinculin and
talin are cytoskeletal proteins that are highly enriched at
myotendinous junctions that we hypothesize to be subject to local
transcriptional regulation. Our findings show that mechanical
stimulation of muscle cells in vivo and in
vitro causes an increase in the expression of vinculin and talin
that is mediated by nitric oxide. Furthermore, nitric oxide-stimulated
increases in vinculin and talin expression occur through a protein
kinase G-dependent pathway and therefore differ from other
mechanisms through which nitric oxide has been shown previously to
modulate transcription. Analysis of vinculin mRNA distribution in
mechanically stimulated muscle fibers shows that the mRNA is highly
concentrated at myotendinous junctions, which supports the hypothesis
that myotendinous junctions are distinct domains in which the
expression of cytoskeletal proteins is modulated by mechanical stimuli
through a nitric oxide and protein kinase G-dependent pathway.
Adaptation of organisms to their environment relies largely on
modifications in gene expression in response to changes in stimuli
applied to constituent cells. The best understood mechanisms through
which environmental signals produce changes in gene expression occur in
systems in which the stimulus produces a change in the chemical
environment surrounding the cell, for example through signaling
information mediated by hormones, growth factors, or cytokines
(e.g. Refs. 1 and 2). However, cells also respond to changes
in their mechanical environment (3), so systems must exist for the
transduction of mechanical information to chemical signals in the cell
that in turn regulate the expression of specific genes.
Skeletal muscle cells, perhaps more than any other cell type, are
profoundly responsive to their mechanical environment. For example,
removal of normal mechanical stimuli from muscle cells in
vivo can result in rapid changes in gene expression, enzyme activity, and protein synthesis and stability (4-9). Application of
mechanical loads to myotubes in vitro yields similar
cellular responses (10-13). Although little is known of the mechanisms
of mechanical signal transduction in muscle, previous investigations have provided evidence that soluble factors released by muscle cells
experiencing loads in vitro may contribute to signaling an
increase in protein synthesis (12). In addition, stretch-activated ion
channels (14) could provide increases in the concentration of specific
cytosolic ions that are capable of activating signaling pathways that
can influence gene expression. However, the extent to which these
systems of mechanical signal transduction may contribute to modifying
the expression of specific proteins in muscle is unknown.
Myotendinous junctions
(MTJs),1 which are highly
specialized sites of force transmission across the muscle cell membrane
(15), are responsive to changes in their mechanical environment (16). Increased mechanical stimulation in vivo or in
vitro causes an increased expression of structural proteins that
are concentrated at these sites (13). The increased concentration at
MTJs of the mRNA encoding proteins whose expression is increased at
MTJs suggests that muscle cell nuclei near the MTJ preferentially
transcribe those mRNAs.
The local regulation of mRNA and protein synthesis at MTJs that are
experiencing modified loading suggests that mechanical signal
transduction that regulates the expression of these molecules occurs at
MTJs. Recently, neuronal nitric-oxide synthase (nNOS) was shown to be
concentrated at MTJs (17), and both its activity and expression are
positively regulated by mechanical loading of muscle in vivo
and in vitro (18-20). Because nitric oxide (NO) has been
shown to modify gene expression in other systems (21-25), it is
feasible, but untested, that increased [NO] that is generated during
increased muscle loading could affect the expression of structural
proteins. Furthermore, nitric oxide that is generated during increased
muscle use has a short half-life (26), so its effects in muscle would
be local and consistent with the expectation that gene expression in
nuclei located near the MTJ would be most affected.
In this investigation, we test the hypothesis that NOS is a mechanical
signal transducer in muscle that positively regulates the expression of
structural proteins enriched at MTJs. We assay the effects of
mechanical stimulation that are mediated by the NOS signaling pathway
on the expression of talin and vinculin, which are cytoskeletal
proteins that are highly enriched at MTJs and are links in a chain of
proteins that couple thin filaments to integrin. Talin was selected for
study because its expression is up-regulated by mechanical stimulation
of muscle (13). Vinculin was selected because previous investigations
have shown that it plays an important role in mechanical coupling in
transmembrane assemblies of structural proteins (27).
In Vitro Mechanical Loading Protocol--
C2C12 muscle cells
were subjected to cyclic strains using a mechanical cell stimulator
(Cell Kinetics, Providence, RI), which consists of a stainless steel
plate containing wells in which the floor is a silastic membrane.
Culture conditions were identical to those used previously (20).
Myotubes were cyclically strained using a 6.7% mean deformation of the
membrane and adherent cells. Five cycles of strain during a 20-s period
followed by 10 s of no strain were applied to the cells, and then
the strain cycle was repeated two more times, followed by a 30-min
period of no strain. Mean strain rate was 3.4%·s Modulation of [NO] and cGMP-dependent Protein
Kinase Activity in Vitro--
NO concentration in vitro was
modulated by the addition of NO donor or NOS inhibitors to cultures. In
addition, potential NO-mediated events in target cells were blocked
downstream of NO stimulation by inhibition of
cGMP-dependent protein kinase (PKG) with KT5823. Cultures
in which NOS activity was inhibited received 100 µM
Nw-nitro-L-arginine methyl ester
(L-NAME) in 10% FBS in DMEM containing no phenol red
immediately prior to the beginning of experimental loading protocols.
Cultures not subjected to experimental inhibition of NOS activity were
subjected to a media exchange at the same time as cultures receiving
L-NAME.
Cultures that were stimulated with exogenous NO donor received 100 µM S-nitroso-N-acetylpenicillamine
(SNAP) in DMEM containing 10% FBS for 2 h prior to collection for
analysis. PKG was inhibited in cultured myotubes by incubation in 2 µM KT5823 for 2 h before analysis. Cells treated
with both SNAP and KT5823 were incubated for 30 min with KT5823 only,
followed by 2 h in SNAP and KT5823. NO concentration in culture
media at the end of the experimental treatments was measured using
previously described procedures (20).
In Vivo Mechanical Loading Protocol--
Modified loading of rat
hindlimb musculature in vivo was achieved using previously
described procedures in which the hindlimb musculature experienced 10 days of unloading followed by 2 days of reloading by normal body weight
(13, 28). At the end of the period of unloading or reloading, animals
were euthanized, and plantaris muscles were collected for analysis.
Modulation of [NO] in Vivo--
Animals experiencing NOS
inhibition during muscle reloading following unloading received water
containing the NOS inhibitor L-NAME at 0.5 mg·ml Northern Blots--
RNA was isolated from whole plantaris
muscles according to the technique of Chomczynski and Sacchi (29).
Electrophoresis and hybridizations were performed as described
previously (20). Transfer efficiency and uniformity of loading were
checked by staining the membrane with methylene blue. Blots were
hybridized with 32P-labeled probes generated by random
priming (Amersham Pharmacia Biotech). Following hybridization at
65 °C, blots were washed with 0.05 M sodium phosphate,
0.75 M sodium chloride, 5 mM EDTA, and 0.1%
SDS for 1 h and exposed to autoradiographic film.
Probes for Northern Hybridization--
The following probes were
used to hybridize Northern blots: 1) mouse talin cDNA (generous
gift from Dr. D. J. G. Rees; University of Oxford, UK); 2)
28 S ribosomal subunit cDNA (30); 3) rat GAPDH cDNA (31); or
4) rat vinculin cDNA. Rat vinculin cDNA probe was synthesized
by PCR of rat cDNA using the following primers: 1) 5' CTG GTG GAC
GAG GCT AT 3' (upstream) and 2) 5' ATG TTT CCA GCC ACA GC 3'
(downstream) which produce a 290-base pair product. The sequence of the
primers was derived from the mouse cDNA
sequence.2 Briefly, RNA was
isolated (21), and 1 µg was used to make cDNA using random
primers (10 ng/µl) and Moloney murine leukemia virus reverse
transcriptase (Life Technologies, Inc.) in 20 µl at 42 °C for 30 min. Following cDNA synthesis, 2 µl of the reaction was used to
perform PCR using TAQ polymerase (Promega), 2.5 mM MgCl2, 4% Me2SO, and 0.2 µM dNTP
(Amersham Pharmacia Biotech). Cycling conditions were 1 min at
94 °C, 1 min at 56 °C, and 1 min at 72 °C for 35 cycles.
Fifteen microliters of the PCR reaction was run to a 1% agarose gel,
and the presence of the 290-base pair product was verified. The
remaining 35 µl of the reaction was placed on a G-50 microspin column
(Amersham Pharmacia Biotech) to remove nucleotides and primers. The
concentration of the purified reaction was determined, and 60 ng was
used in a ligation reaction to pCR2.1 (Invitrogen).
In Situ Reverse Transcription Polymerase Chain Reaction of Single
Muscle Fibers--
Plantaris muscles were fixed in 2%
paraformaldehyde in phosphate-buffered saline for at least 2 days at
6 °C. Muscles were then rinsed in phosphate-buffered saline, and
single muscle fibers were dissected from surrounding tissue, while
keeping the MTJ region of the fibers intact. Fibers were treated with 2 mg/ml of trypsin at 37 °C for 20 min before washing in sterile water followed by 1 min in 100% ethanol and air drying. Fibers were then
incubated with DNase I for 4 h at 37 °C, rinsed in water followed by 1 min in 100% ethanol and air-dried. The RT reaction was
performed using SuperScriptTM (Life Technologies, Inc.)
according to the manufacturer's instructions. The PCR mixture
contained 10 mM Tris-HCl, pH 8.3, 4.5 mM
MgCl2, 200 µM dNTPs, 0.1 unit/ml
Taq, 16 µM
digoxigenin-11-2'-deoxyuridine-5'-triphosphate, 0.08% bovine serum
albumin, and 1.0 µM primers. The same primers were used
for vinculin RT-PCR as were used for generating vinculin cDNA for
Northern analysis. Primer specificity for rat muscle vinculin was
confirmed by RT-PCR of rat muscle RNA using the same RT-PCR conditions
as those used for in situ RT-PCR. PCR on isolated fibers was
performed for 35 cycles (1 min 94 °C, 1 min at 54 °C, 1.5 min at
72 °C; Ericomp Twinblock thermocycler). After completion of the PCR,
the fibers were rinsed in ethanol and then in two changes of TBS (100 mM Tris-HCl, pH 7.6, 150 mM NaCl) for 10 min and then incubated in TBS containing 1% bovine serum albumin for 1 h followed by incubation for 1 h at room temperature in
alkaline phosphatase-conjugated anti-digoxigenin diluted 1:700 diluted in TBS. After 3 washes in TBS, the sections were immersed in TBS at pH
9.5 and containing 5 mM MgCl2 and
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium reagents to
produce a precipitate at the reaction sites. Positive controls
consisted of omitting DNase treatment so that myonuclei containing the
targeted sequence would stain after performing a successful PCR
reaction. Reverse transcriptase was omitted from negative controls.
Vinculin mRNA distribution was compared with the distribution of
mRNA Stability Assay--
The possibility that SNAP
treatments may reduce the rate of mRNA degradation rather than
increasing transcription was tested by assaying for the rate of decline
in concentration of vinculin and talin mRNA in cells treated with
an inhibitor of transcription. C2C12 myotube cultures were incubated
with 5 µg/ml actinomycin D in 10% FBS in DMEM for 0, 2, 8, or
24 h. The cells were then collected for RNA isolation and Northern
analysis for changes in vinculin and talin mRNA concentrations.
Densitometry--
Relative mRNA concentrations were
determined by scanning densitometry (Alpha Innotec) and expressed in
arbitrary units. Comparisons were made only between those experimental
and control samples that were run in the same gel and probed in the
same autoradiograph. The significance of differences between the
concentration of any given protein or mRNA in loaded and control
samples was tested by the Mann-Whitney test, with confidence limit set
at p < 0.05.
Mechanical Stimulation Increases Talin and Vinculin Expression in
Myotubes via an NO-dependent Mechanism--
C2C12 myotubes
subjected to mechanical stimulation by periodic cyclic loading in
vitro for 24 h showed large increases in the concentration of
both talin and vinculin mRNA by approximately 3- and 2.5-fold,
respectively, compared with control myotubes not subjected to
stimulation (Fig. 1). The presence of the
NOS inhibitor L-NAME prevented the increases in talin and
vinculin mRNA concentrations caused by mechanical stimulation of
myotubes in vitro (Fig. 1). Measurement of NO concentration
in the culture media of mechanically stimulated myotubes and
unstimulated controls showed that stimulation nearly doubled NO
production by myotubes, from 0.5 to 0.9 pmol NO/mg/min (±0.04;
n = 4).
Exogenous NO Stimulates Vinculin and Talin Expression via
PKG-dependent Mechanism--
Addition of 100 µM SNAP produced 30 nM NO/mg/min (± 0.01;
n = 3) over the 2-h incubation
period. The increased NO concentration was accompanied by an increase in the concentration of vinculin mRNA to 170% of control values and an increase in the
concentration of talin mRNA to approximately 260% of control
values (Table I). Inhibition of
cGMP-dependent protein kinase with KT5823 prevented the
increase in vinculin or talin mRNA stimulated by SNAP (Fig. 2). PKG
inhibition by KT5823 in the presence of SNAP reduced vinculin mRNA
concentration below that of control cultures that were not stimulated
by SNAP. Application of KT5823 alone did not significantly decrease
vinculin or talin mRNA concentrations (Fig. 2) which indicates that
the KT5823 inhibition of the SNAP-stimulated increase of talin and
vinculin mRNA does not occur through inhibition of a
NO-independent positive regulator of their expression. However, KT5823 application to myotubes in the absence of SNAP resulted in a
significant increase in vinculin mRNA concentration, which indicates that there must be other NO-independent, PKG-modulated controls on vinculin expression that remain unidentified.
Talin and Vinculin mRNA Half-life Measurements--
Stability
of talin and vinculin mRNAs were measured by assaying for changes
in their concentration over time in the presence of actinomycin D, used
to inhibit transcription. These assays showed that the half-life for
talin mRNA stability in C2C12 myotubes is approximately 12.1 h, and the half-life for vinculin mRNA is approximately 27.3 h
(Figs.
3-5).
Increased Talin and Vinculin Expression during Muscle Loading Is
Inhibited by NOS Inhibition--
Increased loading of plantaris
muscles by 2 days of normal weight-bearing following a 10-day period of
unloading produced an increase in vinculin
mRNA concentration to 2.6 times
control and in talin mRNA to 1.8 times control concentrations (Fig.
6; Table II). The increased
concentrations of both talin and vinculin mRNA during increased
muscle loading was greatly attenuated in animals that received
L-NAME in their drinking water during the reloading period
(Fig. 6). GAPDH mRNA concentration as a fraction of total mRNA
decreased during muscle reloading, but L-NAME had no
detectable influence on the effect of reloading on GAPDH mRNA concentration. Thus, NOS inhibition does not affect the changes in
concentration of all mRNAs that are caused by muscle reloading.
Vinculin mRNA was primarily concentrated at MTJs in muscles
experiencing increased loading (Fig. 7),
as has been shown previously for talin mRNA (13). Negative control
fibers showed no labeling at the MTJ following the in situ
RT-PCR procedure. Positive control fibers showed strong labeling of
nuclei following the in situ RT-PCR procedure (Fig. 7).
In situ RT-PCR of Our findings show that the increases in talin and vinculin
mRNAs that result from mechanical stimulation of muscle fibers are
mediated by NO. Thus, NOS acts as a mechanical signal transducer in
muscle cells and may couple modifications in the mechanical environment
to changes in gene expression. Several previous investigations have
reported that increased expression of structural proteins in skeletal
muscle occurs when muscle is subjected to increased mechanical
stimulation (9, 13, 34, 35), but little is known of the mechanisms by
which those stimuli from the mechanical environment are transduced into
chemical information that can influence gene expression. Although NO
synthesis has been shown to be positively regulated by mechanical
stimulation of cells in bone (36), endothelial cells (37, 38), and
skeletal muscle (18-20), and NO is a famously pleuripotent signaling
molecule (26, 39), the present findings are the first to show that it
functions in modifying muscle gene expression in response to modified use.
The hypothesis that NOS could function as a mechanical signal
transducer in skeletal muscle was supported by several previous investigations. First, nNOS is highly concentrated at MTJs (17), which
are specialized for force transduction across the muscle cell membrane
(15). This localization would place nNOS at an optimal site for sensing
changes in the mechanical environment. Furthermore, increased skeletal
muscle loading causes an increase both in nNOS expression (20) and
activity (18, 20), and NO has been shown to function as a signaling
molecule in several cell types (39). Finally, the short half-life of NO
(26) suggests that it would locally regulate changes in transcriptional
activity. This local regulatory effect may have particular functional
significance in skeletal muscle where the transcriptional activities of
individual nuclei located in a single muscle fiber can function
independently. This independent regulation of transcriptional activity
of individual myonuclei in a single cell has been best demonstrated for
myonuclei located near the neuromuscular junction in which the
increased expression of acetylcholine receptor subunits can be
regulated independently of non-neuromuscular junction nuclei in the
same cell (40, 41). The finding reported here that NO transduces mechanical signals to influence the expression of talin and vinculin and that NOS, NO, and the mRNAs of talin and vinculin are most concentrated at MTJs indicates that MTJs may also be a distinct nuclear
domain in muscle cells in which NO plays a role in the local modulation
of transcription. Other evidence indicating that MTJs may be distinct
nuclear domains in muscle includes the findings that the mRNA for
myosin heavy chain (34) and talin (13) increase in concentration at the
MTJ during modified muscle use.
The observations reported here indicate that NO-mediated modulation of
talin and vinculin mRNA concentrations occurs primarily by
influencing the rate of transcription, although the possibility that
there is some NO-mediated influence on talin and vinculin mRNA
stability cannot be excluded entirely. This conclusion is supported by
the finding that NO stimulation of myotubes for 24 h caused an
approximately 170% increase in vinculin mRNA and 260% increase in
talin mRNA, although the half-lives of those mRNAs were
approximately 27 and 12 h, respectively. If NO were causing the
observed increases in mRNA concentrations reported here solely through RNA stabilization, the maximum increase that would be observed
in 24 h stimulation would be approximately 44% for vinculin and
93% for talin, which would be insufficient to explain the majority of
the NO-mediated increase in mRNA concentrations.
Although there are several mechanisms through which NO can function as
a signaling molecule, to our knowledge the only previously identified
mechanism through which it has been shown to influence transcription is
through structural modification of transcription factors (23-25). For
example, c-Fos, c-Jun, and NF- Other mechanisms may also exist at MTJs for mechanical signal
transduction that may influence the expression of genes for cytoskeletal proteins. The integrin-associated complex of proteins is
highly concentrated at MTJs (15) and provides a prominent candidate
system for this function because integrins have also been shown to
function in signal transduction. Mechanical loads placed on integrins
and associated proteins influence the assembly of complexes of
structural proteins at the loading site (42-44) and activate kinases
concentrated at those sites (42). Although integrin loading per
se has not been shown to regulate the expression of genes encoding
cytoskeletal proteins, integrin binding of extracellular matrix
molecules can dramatically influence gene expression (e.g. Refs. 32, 45, and 46). The co-distribution of nNOS and the integrin
complex and the role of both proteins in influencing the response of
cells to changes in their mechanical environment support the
possibility that future investigations will show synergistic interactions between the two systems when muscle cells respond to
changes in their mechanical environment.
*
This work was supported by Grant AR40343 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
J.-L. C. Coll, EMBL accession number
L18880.
The abbreviations used are:
NO, nitric oxide;
NOS, nitric-oxide synthase;
nNOS, neuronal nitric-oxide synthase;
MTJ, myotendinous junction;
DMEM, Dulbecco's modified Eagle's medium;
PKG, cGMP-dependent protein kinase;
L-NAME, (Nw-nitro-L-arginine methyl ester;
SNAP, S-nitroso-N-acetylpenicillamine;
FBS, fetal
bovine serum;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
RT-PCR, reverse transcriptase-polymerase chain reaction.
Nitric-oxide Synthase Is a Mechanical Signal Transducer That
Modulates Talin and Vinculin Expression*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1. The
sequence was repeated 47 times, over the course of 24 h. Cultures
were then inspected with an inverted microscope to confirm that the
myotubes remained attached to the substratum. Control cultures were
grown under identical conditions, but they were not subjected to loading.
1 that was provided ad libitum starting
1 day prior to reloading. Control animals received untreated drinking water.
-actin mRNA by in situ RT-PCR on single rat plantaris
fibers using methods similar to those used for vinculin mRNA
localization. The primers used to generate a
-actin 296-base pair
product were 5' CGT TGA CAT CCG TAA AGA CCT CTA 3' (upper primer) and
5' TAA AAC GCA GCT CAG TAA CAG TCC G 3' (lower primer) (33). However, PCR on fibers used for
-actin localization used 30 cycles of PCR
(94 °C for 1 min followed by 58 °C for 1 min and 72 °C for 2 min).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (45K):
[in a new window]
Fig. 1.
Northern analysis of mRNA collected from
C2C12 myotubes grown on gelatin-coated, silastic membrane and assayed
for vinculin mRNA (upper panel), talin mRNA
(middle), or 28 S ribosomal subunit
(lower). A, myotubes not subjected to
mechanical stimulation; B, myotubes subjected to mechanical
stimulation prior to collection for RNA isolation; C,
myotubes mechanically stimulated while in culture medium; and
D, myotubes mechanically stimulated while in culture medium
containing L-NAME.

View larger version (55K):
[in a new window]
Fig. 2.
Northern analysis of mRNA collected from
C2C12 myotubes and assayed for vinculin mRNA (upper
panel), talin mRNA (middle), or 28 S
ribosomal subunit (lower). A,
myotubes in culture medium only; B, myotubes in culture
medium containing SNAP for 24 h; C, myotubes in culture
medium containing SNAP and KT5823 for 24 h; and D,
myotubes in culture medium containing KT5823 for 24 h.
Relative density of signals in Northern analysis of vinculin and talin
mRNAs for myotubes treated with NO donor or PKG inhibitor

View larger version (31K):
[in a new window]
Fig. 3.
Northern analysis of mRNA collected from
C2C12 myotubes and assayed for vinculin mRNA (upper
panel) or talin mRNA (lower).
A, myotubes in culture media only; B, myotubes in
culture media containing actinomycin D for 2 h; C,
myotubes in culture media containing actinomycin D for 8 h;
D, myotubes in culture media containing actinomycin D for
24 h.

View larger version (21K):
[in a new window]
Fig. 4.
Linear regression of densitometry of
autoradiograph of Northern analysis for vinculin mRNA collected
from myotubes cultured in media containing actinomycin D. r =
0.73; p = 0.007.

View larger version (21K):
[in a new window]
Fig. 5.
Linear regression of densitometry of
autoradiograph of Northern analysis for talin mRNA collected from
myotubes cultured in media containing actinomycin D. r =
0.96; p < 0.0001.

View larger version (82K):
[in a new window]
Fig. 6.
Northern analysis of mRNA collected from
rat plantaris muscles and assayed for vinculin mRNA (upper
panel), talin mRNA (second from
top), GAPDH mRNA (third from
top), or 28 S ribosomal subunit
(lower). A, muscles collected from
animals after 10 days unloading by hindlimb suspension. B,
muscles collected from animals after 10 days unloading by hindlimb
suspension, followed by 2 days of reloading by normal weight-bearing
while receiving drinking water ad libitum.
C, muscles collected from animals after 10 days unloading by
hindlimb suspension, followed by 2 days of reloading by normal
weight-bearing while receiving drinking water containing
L-NAME ad libitum.
Relative density of signals in Northern analysis of select mRNAs in
plantaris muscles of animals experiencing modified muscle loading
-actin mRNA showed no detectable
differences in the concentration of that mRNA at MTJ and non-MTJ
regions of the fibers on reloaded muscles (Fig. 8). Thus, the relatively high
concentration of vinculin and talin mRNA at MTJs does not occur for
all mRNA. RT-PCR showed that the primers and RT-PCR conditions used
for in situ RT-PCR yielded products only of the predicted
size for vinculin or
-actin (Fig. 9),
indicating that the reaction products seen by in situ RT-PCR were specific for vinculin or
-actin mRNA.

View larger version (79K):
[in a new window]
Fig. 7.
Muscle fibers from rat plantaris muscle
collected after 10 days of hindlimb unloading and 2 days of reloading
and then subjected to in situ RT-PCR for vinculin
mRNA. Group of three positive control muscle fibers
(A) for which DNase was eliminated from the in
situ RT-PCR protocol. The dark structures at the
surface of the fibers are nuclei. Other panels show single fibers
(B and C) and a bundle of 3 fibers (D)
following in situ RT-PCR for vinculin mRNA. The most
dense reaction product is at the MTJ. Fiber diameter is approximately
60 µm.

View larger version (65K):
[in a new window]
Fig. 8.
Muscle fibers from rat plantaris muscle
collected after 10 days of hindlimb unloading and 2 days of reloading
and then subjected to in situ RT-PCR for
-actin mRNA. A, experimental
sample showing
-actin mRNA found at similarly high
concentrations throughout the fibers. B, negative control
treated identically as fibers shown in A, except reverse
transcriptase was eliminated from the reaction mixture.

View larger version (44K):
[in a new window]
Fig. 9.
RT-PCR products of rat plantaris muscle
mRNA in which an approximately 290-base pair product was amplified
using primers specific for either
-actin
(lane B) or vinculin (lane C).
DNA ladder is shown in left-hand lane (A).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B binding affinities for target DNA
sequences are all influenced by NO (23-25). Current evidence indicates
that NO modifies transcription factors by S-nitrosylation of
cysteines located in or near DNA binding domains (23-25) and that the
NO-mediated effects are independent of guanylate cyclase activation
(21). The present findings show that NO modulation of talin and
vinculin expression is blocked by inhibition of PKG and therefore NO is
not influencing transcription of talin and vinculin through direct
interaction with transcription factors but rather through a cGMP- and
PKG-dependent pathway. NO modulation of talin and vinculin
expression also differs from the mechanisms through which it modulates
the expression of genes regulated by AP-1 or NF-
B (21-25) in that
NO is a positive modulator of talin and vinculin but negatively
regulates genes whose expression is influenced by AP-1 or NF-
B binding.
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Physiological
Science, 621 Young Dr., University of California, Los Angeles, CA
90095-1527. Tel.: 310-206-3395; Fax: 310-206-9184; E-mail: jtidball@ physci.ucla.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Herschman, H. R.
(1991)
Annu. Rev. Biochem.
60,
281-319[CrossRef][Medline]
[Order article via Infotrieve]
2.
Taga, T.,
and Kishimoto, T.
(1992)
FASEB J.
6,
3387-3396[Abstract]
3.
Watson, P. A.
(1991)
FASEB J.
5,
2013-2019[Abstract]
4.
Templeton, G. H.,
Padalino, M.,
Manton, J.,
Glasberg, M.,
Silver, C. J.,
Lilver, P.,
DeMartino, G.,
Leconey, T.,
Klug, G.,
Hagler, H.,
and Sutko, J. L.
(1984)
J. Appl. Physiol.
56,
278-286 5.
Fitts, R. H.,
Metzger, J. M.,
Riley, D. A.,
and Unsworth, B. R.
(1986)
J. Appl. Physiol.
60,
1946-1953 6.
Thomason, D. B.,
Herrick, R. E.,
Surdyka, D.,
and Baldwin, K. M.
(1987)
J. Appl. Physiol.
63,
130-137 7.
Thomason, D. B.,
Biggs, R. B.,
and Booth, F. W.
(1989)
Am. J. Physiol.
257,
R300-R305 8.
McDonald, K. S.,
and Fitts, R. H.
(1995)
J. Appl. Physiol.
79,
1796-1802 9.
Caiozzo, V. J.,
Haddad, F.,
Baker, M. J.,
and Baldwin, K. M.
(1996)
J. Appl. Physiol.
80,
1503-1512 10.
Vandenburgh, H. H.,
and Kaufman, S.
(1979)
Science
203,
265-268 11.
Vandenburgh, H. H.,
Hatfaludy, S.,
Karlisch, P.,
and Shansky, J.
(1989)
Am. J. Physiol.
256,
C674-C682 12.
Vandenburgh, H. H.,
Shansky, J.,
Karlisch, P.,
and Solerssi, R. L.
(1993)
J. Cell. Physiol.
155,
63-71[CrossRef][Medline]
[Order article via Infotrieve]
13.
Frenette, J.,
and Tidball, J. G.
(1998)
Am. J. Physiol.
275,
C818-C825 14.
Sachs, F.
(1987)
Fed. Proc.
46,
12-16[Medline]
[Order article via Infotrieve]
15.
Tidball, J. G.
(1991)
J. Biomech.
24 Suppl. 1,
43-52
16.
Tidball, J. G.,
and Quan, D. M.
(1992)
J. Appl. Physiol.
73,
59-64 17.
Chang, W. J.,
Iannaccone, S. T.,
Lau, K. S.,
Masters, B. S. S.,
McCabe, T. J.,
McMillan, K.,
Padre, R. C.,
Spencer, M. J.,
Tidball, J. G.,
and Stull, J. T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9142-9147 18.
Balon, T. W.,
and Nadler, J. L.
(1994)
J. Appl. Physiol.
77,
2519-2521 19.
Reiser, P. J.,
Kline, W. O.,
and Vaghy, P. L.
(1997)
J. Appl. Physiol.
82,
1250-1255 20.
Tidball, J. G.,
Lavergne, E.,
Lau, K. S.,
Spencer, M. J.,
Stull, J. T.,
and Wehling, M.
(1998)
Am. J. Physiol.
275,
C260-C266 21.
Peng, H.-B.,
Rajavashisth, T. B.,
Libby, P.,
and Liao, J. K.
(1995)
J. Biol. Chem.
270,
17050-17055 22.
Peng, H.-B.,
Libby, P.,
and Liao, J. K.
(1995)
J. Biol. Chem.
270,
14214-14219 23.
Matthews, J. R.,
Botting, C. H.,
Panico, M.,
Morris, H. R.,
and Hay, R. T.
(1996)
Nucleic Acids Res.
24,
2236-2242 24.
DelaTorre, A.,
Schroeder, R. A.,
and Kuo, P. C.
(1997)
Biochem. Biophys. Res. Commun.
238,
703-706[CrossRef][Medline]
[Order article via Infotrieve]
25.
Nikitovic, D.,
Holmgren, A.,
and Spyrou, G.
(1998)
Biochem. Biophys. Res. Commun.
242,
109-112[CrossRef][Medline]
[Order article via Infotrieve]
26.
Lowenstein, C. J.,
Dinerman, J. L.,
and Snyder, S. H.
(1994)
Ann. Intern. Med.
124,
227-237
27.
Ezzell, R. M.,
Goldmann, W. H.,
Wang, N.,
Parasharama, N.,
and Ingber, D.
(1997)
Exp. Cell Res.
231,
14-26[CrossRef][Medline]
[Order article via Infotrieve]
28.
Morey-Holton, E.,
and Wronski, J.
(1981)
Physiologist
24 (suppl.),
45-48
29.
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159[Medline]
[Order article via Infotrieve]
30.
Harrington, C. A.,
and Chikaraishi, D. M.
(1983)
Nucleic Acids Res.
11,
3317-3332 31.
Fort, P.,
Marty, L.,
Piechaczyk, M.,
El Sabrouty, S.,
Dani, D.,
Jeanteur, P.,
and Blanchard, J. M.
(1985)
Nucleic Acids Res.
13,
1431-1432 32.
Pacifici, R.,
Basilico, C.,
Roman, J.,
Zutter, M. M.,
Santoro, S. A.,
and McCracken, R.
(1992)
J. Clin. Invest.
89,
61-67
33.
Adams, J. W.,
Migita, D. S., Yu, M. K.,
Young, R.,
Hellickson, M. S.,
Castro-Vargas, F. E.,
Domingo, J. D.,
Lee, P. H.,
Bui, J. S.,
and Henderson, S. A.
(1996)
J. Biol. Chem.
271,
1179-1186 34.
Dix, D. J.,
and Eisenberg, B. R.
(1990)
J. Cell Biol.
111,
1885-1894 35.
Baldi, J. C.,
and Reiser, P. J.
(1995)
J. Muscle Res. Cell Motil.
16,
587-594[CrossRef][Medline]
[Order article via Infotrieve]
36.
Pitsillides, A. A.,
Rawlinson, S. C. F.,
Suswillo, R. F. L.,
Rourrin, S.,
Azman, G.,
and Lanyon, L. E.
(1995)
FASEB J.
9,
1614-1622[Abstract]
37.
Awolski, M. A.,
Sessa, W. C.,
and Sumpio, B. E.
(1995)
J. Clin. Invest.
96,
1449-1454
38.
Uematsu, M.,
Ohara, Y.,
Navas, J. P.,
Nishida, K.,
Murphy, T. J.,
Alexander, R. W.,
Nerem, R. M.,
and Harrison, D. G.
(1995)
Am. J. Physiol.
269,
C1371-C1378 39.
Hobbs, A. J.,
and Ignarro, L. J.
(1996)
Methods Enzymol.
269,
134-148[Medline]
[Order article via Infotrieve]
40.
Simon, M. S.,
Hoppe, P.,
and Burden, S. J.
(1992)
Development
114,
545-553[Abstract]
41.
Ahn Jo, S.,
Zhu, X.,
Marchionni, M. A.,
and Burden, S. J.
(1995)
Nature
373,
158-161[CrossRef][Medline]
[Order article via Infotrieve]
42.
Chrzanowska-Wodnicka, M.,
and Burridge, K.
(1996)
J. Cell Biol.
133,
1403-1415 43.
Choquet, D.,
Felsenfeld, D. P.,
and Sheetz, M.
(1997)
Cell
88,
39-48[CrossRef][Medline]
[Order article via Infotrieve]
44.
Sharp, W. W.,
Simpson, D. G.,
Borg, T. K.,
Samarel, A. M.,
and Terracio, L.
(1997)
Am. J. Physiol.
273,
H546-H556 45.
Dike, L. E.,
and Farmer, S. R.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
6792-6796 46.
Shaw, R. J.,
Doherty, D. E.,
Ritter, A. G.,
Benedict, S. H.,
and Clark, R. A. F.
(1990)
J. Cell Biol.
111,
2139-2148
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. J. Zhang, G. A. Truskey, and W. E. Kraus Effect of cyclic stretch on beta1D-integrin expression and activation of FAK and RhoA Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2057 - C2069. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Sidell and K. M. O'Brien When bad things happen to good fish: the loss of hemoglobin and myoglobin expression in Antarctic icefishes J. Exp. Biol., May 15, 2006; 209(10): 1791 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. KUMAR, R. MURPHY, P. ROBINSON, L. WEI, and A. M. BORIEK Cyclic mechanical strain inhibits skeletal myogenesis through activation of focal adhesion kinase, Rac-1 GTPase, and NF-{kappa}B transcription factor FASEB J, October 1, 2004; 18(13): 1524 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiao, A. Fond, B. Deng, M. Wehling-Henricks, M. E. Adams, S. C. Froehner, and J. G. Tidball Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking {alpha}- and {beta}1-syntrophins Hum. Mol. Genet., September 1, 2004; 13(17): 1873 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Zhang, W. E. Kraus, and G. A. Truskey Stretch-induced nitric oxide modulates mechanical properties of skeletal muscle cells Am J Physiol Cell Physiol, August 1, 2004; 287(2): C292 - C299. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fan, E. Roy, L. Zhu, T. C. Murphy, C. Ackert-Bicknell, C. M. Hart, C. Rosen, M. S. Nanes, and J. Rubin Nitric Oxide Regulates Receptor Activator of Nuclear Factor-{kappa}B Ligand and Osteoprotegerin Expression in Bone Marrow Stromal Cells Endocrinology, February 1, 2004; 145(2): 751 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D'Addario, P. D. Arora, R. P. Ellen, and C. A. G. McCulloch Regulation of Tension-induced Mechanotranscriptional Signals by the Microtubule Network in Fibroblasts J. Biol. Chem., December 26, 2003; 278(52): 53090 - 53097. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Y. Siu, D. D. Mruk, W. M. Lee, and C. Y. Cheng Adhering Junction Dynamics in the Testis Are Regulated by an Interplay of {beta}1-Integrin and Focal Adhesion Complex-Associated Proteins Endocrinology, May 1, 2003; 144(5): 2141 - 2163. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Ervasti Costameres: the Achilles' Heel of Herculean Muscle J. Biol. Chem., April 11, 2003; 278(16): 13591 - 13594. [Full Text] [PDF] |
||||
![]() |
Y. Nagasawa, M. Takenaka, J. Kaimori, Y. Matsuoka, Y. Akagi, M. Tsujie, E. Imai, and M. Hori Rapid and diverse changes of gene expression in the kidneys of protein-overload proteinuria mice detected by microarray analysis Nephrol. Dial. Transplant., May 1, 2001; 16(5): 923 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Reid Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Redox modulation of skeletal muscle contraction: what we know and what we don't J Appl Physiol, February 1, 2001; 90(2): 724 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Smith, J. D. Smith, and D. S. Criswell Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload J Appl Physiol, May 1, 2002; 92(5): 2005 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D'Addario, P. D. Arora, J. Fan, B. Ganss, R. P. Ellen, and C. A. G. McCulloch Cytoprotection against Mechanical Forces Delivered through beta 1 Integrins Requires Induction of Filamin A J. Biol. Chem., August 17, 2001; 276(34): 31969 - 31977. [Abstract] [Full Text] [PDF] |
||||
| ||||||